Skip to main content
Figure 5 | Breast Cancer Research

Figure 5

From: A divergent role for estrogen receptor-beta in node-positive and node-negative breast cancer classified according to molecular subtypes: an observational prospective study

Figure 5

Kaplan-Meier estimates of disease-free survival for estrogen receptor-beta (ER-β) status. Kaplan-Meier estimates of disease-free survival for estrogen receptor-beta (ER-β) status in the whole patient group (a), in the 210 node-negative patients treated exclusively with hormonal therapy (b), in the 240 node-negative patients subjected to adjuvant chemotherapy followed or not followed by hormonal therapy (c), and in the 246 node-positive patients subjected to adjuvant chemotherapy followed or not followed by hormonal therapy (d). P values were calculated using the log-rank test.

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us